InnoSer is an innovative, international, contract research organization focused on tailoring project plans that strategically adapt our services to support your specific project needs in drug discovery and preclinical drug development.
Low success rates in drug development have a profound societal and economic impact. Predictive quality in the preclinical phase is critical for the effective and safe compounds and the translation towards its use in humans during clinical trials.
InnoSer specializes in oncology, polycystic kidney disease, Alzheimer’s disease, Parkinson’s disease and cardiovascular diseases. Our expertise involves both in-vivo and in-vitro modeling in these areas. This offers our clients reliable and meaningful screening platforms that can be customized towards their specific needs.